Lyell Immunopharma (LYEL) Shareholder's Equity (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Lyell Immunopharma | 373.31 Mn | 373.31 Mn | - | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.67 Mn |
| Dec 31, 2025 | 248.20 Mn |
| Sep 30, 2025 | 329.12 Mn |
| Jun 30, 2025 | 298.92 Mn |
| Mar 31, 2025 | 336.52 Mn |
| Dec 31, 2024 | 382.82 Mn |
| Sep 30, 2024 | 530.70 Mn |
| Jun 30, 2024 | 566.50 Mn |
| Mar 31, 2024 | 603.16 Mn |
| Dec 31, 2023 | 654.95 Mn |
| Sep 30, 2023 | 697.57 Mn |
| Jun 30, 2023 | 736.86 Mn |
| Mar 31, 2023 | 783.83 Mn |
| Dec 31, 2022 | 833.25 Mn |
| Sep 30, 2022 | 820.03 Mn |
| Jun 30, 2022 | 868.04 Mn |
| Mar 31, 2022 | 881.25 Mn |
| Dec 31, 2021 | 929.79 Mn |
| Sep 30, 2021 | 986.47 Mn |
| Jun 30, 2021 | 1.02 Bn |
| Mar 31, 2021 | -334.05 Mn |
| Dec 31, 2020 | -292.53 Mn |
| Sep 30, 2020 | -266.64 Mn |
| Jun 30, 2020 | -240.11 Mn |
| Dec 31, 2019 | -111.11 Mn |